MXRA5 Is a Novel Immune-Related Biomarker That Predicts Poor Prognosis in Glioma

BACKGROUND: Glioma is the most common primary intracranial tumor and is associated with poor prognosis. Identifying effective biomarkers for glioma is particularly important. MXRA5, a secreted glycoprotein, is involved in cell adhesion and extracellular matrix remodeling and has been reported to be...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Jin-Zhang, Zhang, Jin-Hao, Li, Jia-Bo, Yuan, Feng, Tong, Lu-Qing, Wang, Xu-Ya, Chen, Lu-Lu, Fan, Xiao-Guang, Zhang, Yi-Ming, Ren, Xiao, Zhang, Chen, Yu, Sheng-Ping, Yang, Xue-Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8211501/
https://www.ncbi.nlm.nih.gov/pubmed/34211612
http://dx.doi.org/10.1155/2021/6680883

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8211501/
https://www.ncbi.nlm.nih.gov/pubmed/34211612
http://dx.doi.org/10.1155/2021/6680883

Ejemplares similares